| Patents for A61P 17 - Drugs for dermatological disorders (106,455) |
|---|
| 04/24/2001 | US6222036 Reacting 2-thio-4-dimethyoxymethyl-pyrimidine with acetic acid and catalytic amount of concetrated sulfuric acid to produce 2-thiopyrimidine aldehyde |
| 04/24/2001 | US6222016 Amino acid sequence of protein involved in chromosome partitioning; drug screening of bacteriostats and bactericides; antibodies |
| 04/24/2001 | US6221911 Reducing subcutaneous fat deposits in a subject; improving the skin condition of a subject |
| 04/24/2001 | US6221891 Crystal form of N-(4-triflouromethylphenyl)-5-methylisoxazole-4-carboxamide |
| 04/24/2001 | US6221856 Inositol derivatives for inhibiting superoxide anion production |
| 04/24/2001 | US6221660 Amino acid sequence; recombinant production; drug screening using membrane preparations |
| 04/24/2001 | US6221372 Cosmetic cleansing and skin care preparation containing plant and algae extracts |
| 04/24/2001 | US6221371 Pseudoceramides, and dermatologic external preparations containing the same |
| 04/24/2001 | CA2165192C Fluoroalkoxy-substituted benzamides and their use as cyclic nucleotide phosphodiesterase inhibitors |
| 04/19/2001 | WO2001027268A2 Cell-permeable peptide inhibitors of the jnk signal transduction pathway |
| 04/19/2001 | WO2001027254A2 Gene transfer vectors for treating autoimmune diseases and diseases with immunopathogenesis by therapy |
| 04/19/2001 | WO2001027147A1 A novel molecule |
| 04/19/2001 | WO2001027136A2 Peptides which stimulate the immune response and tissue regeneration |
| 04/19/2001 | WO2001027135A2 Regulators of the hedgehog pathway, compositions and uses related thereto |
| 04/19/2001 | WO2001027131A1 Purine derivatives |
| 04/19/2001 | WO2001027130A1 Purine derivatives |
| 04/19/2001 | WO2001027128A1 C-aryl glucoside sglt2 inhibitors |
| 04/19/2001 | WO2001027119A2 Substance library containing bicyclic imidazo-5-yl-amines and/or bicyclic imidazo-3-yl-amines |
| 04/19/2001 | WO2001027113A2 PYRAZOLO `4,3-d! PYRIMIDINE DERIVATIVES |
| 04/19/2001 | WO2001027109A2 Tert.-butyl-(7-methyl-imidazo[1,2-a]pyridine-3-yl)-amine derivatives |
| 04/19/2001 | WO2001027104A1 Substituted imidazolidinone derivatives |
| 04/19/2001 | WO2001027102A1 Substituted diazepanes |
| 04/19/2001 | WO2001027101A2 Anhydrous salt |
| 04/19/2001 | WO2001027089A1 Pyrimidine derivatives |
| 04/19/2001 | WO2001027084A1 Beta disubstituted metalloprotease inhibitors |
| 04/19/2001 | WO2001027081A1 6-position substituted indoline, production and use thereof as a medicament |
| 04/19/2001 | WO2001027079A2 Compositions and methods of use of ligands that bind components of the blood coagulation/clotting pathway for the treatment of cancer and angiogenic-based disease |
| 04/19/2001 | WO2001027068A1 Biaryl ether derivatives useful as monoamine reuptake inhibitors |
| 04/19/2001 | WO2001026686A1 Skin immune function controlling agents |
| 04/19/2001 | WO2001026685A1 Remedies for intractable wound |
| 04/19/2001 | WO2001026670A1 Skin-care agents, skin antiaging agents, whitening agents and external skin preparations |
| 04/19/2001 | WO2001026661A1 Compositions comprising oxophosphonate-based metalloproteinase inhibitors |
| 04/19/2001 | WO2001026652A1 Fab i inhibitors |
| 04/19/2001 | WO2001026644A2 Mediators of hedgehog signaling pathways, compositions and uses related thereto |
| 04/19/2001 | WO2001026636A1 Superficial therapeutic system for topically applying acetylsalicylic acid, for the treatment of acne-related diseases |
| 04/19/2001 | WO2001026618A2 Composition, especially a cosmetic composition, containing a steroid and a liposoluble uv filter |
| 04/19/2001 | WO2001026606A2 Treatment of scar tissue using lipoic acid |
| 04/19/2001 | WO2001001963A8 A method for the improvement of transport across adaptable semi-permeable barriers |
| 04/19/2001 | WO2000068380A3 Extracellular matrix and adhesion-associated proteins |
| 04/19/2001 | WO2000046198A8 Anti-inflammatory indole derivatives |
| 04/19/2001 | WO2000026245A3 Human membrane transport proteins |
| 04/19/2001 | WO2000012720A9 Elongase genes and uses thereof |
| 04/19/2001 | WO1998008546A8 Therapeutic combinations of rar antagonists and rxr agonists and use thereof |
| 04/19/2001 | DE19949897A1 Shaped article, e.g. in stick form, for controlled release of drugs in wounds or body cavities, comprising hydrophilic outer phase, lipophilic inner phase and drug, e.g. antibiotic |
| 04/19/2001 | CA2388962A1 A molecular framework for amino acids or heterologous amino acid sequences |
| 04/19/2001 | CA2387604A1 Peptides which stimulate the immune response and tissue regeneration |
| 04/19/2001 | CA2387535A1 Substituted imidazolidinone derivatives |
| 04/19/2001 | CA2387314A1 Compositions and methods of use of ligands that bind components of the blood coagulation/clotting pathway for the treatment of cancer and angiogenic-based disease |
| 04/19/2001 | CA2387199A1 Remedies for intractable wound |
| 04/19/2001 | CA2387184A1 Cell-permeable peptide inhibitors of the jnk signal transduction pathway |
| 04/19/2001 | CA2387146A1 Gene transfer vectors for treating autoimmune diseases and diseases with immunopathogenesis by therapy |
| 04/19/2001 | CA2386848A1 Compositions comprising oxophosphonate-based metalloproteinase inhibitors |
| 04/19/2001 | CA2386804A1 Tert.-butyl-(7-methyl-imidazo[1,2-a]pyridine-3-yl)-amine derivatives |
| 04/19/2001 | CA2386485A1 Beta disubstituted metalloprotease inhibitors |
| 04/19/2001 | CA2385139A1 Skin-beautifying agent, anti-aging agent for the skin, whitening agent and external agent for the skin |
| 04/19/2001 | CA2382937A1 Anhydrous salt |
| 04/19/2001 | CA2382605A1 Pyrimidine derivatives |
| 04/19/2001 | CA2355357A1 Composition, especially a cosmetic composition, containing a steroid and a liposoluble uv filter |
| 04/18/2001 | EP1092719A2 Imidazo[5,1-f][1,2,4]triazine derivatives |
| 04/18/2001 | EP1092433A2 Compositions and methods for treating or preventing inflammatory diseases |
| 04/18/2001 | EP1092423A2 Use of DHEA or its precursors and metabolites as skin depigmentation agents |
| 04/18/2001 | EP1092019A1 Human homologue of unc-53 protein of c. elegans |
| 04/18/2001 | EP1091943A1 Non-peptidyl inhibitors of vla-4 dependent cell binding useful in treating inflammatory, autoimmune, and respiratory diseases |
| 04/18/2001 | EP1091942A1 Potassium channel blocking agents |
| 04/18/2001 | EP1091760A1 Pharmaceutical composition containing an ester or amide pla2 inhibitor |
| 04/18/2001 | EP1091735A1 Application for utility patent for improved enriched platelet wound healant |
| 04/18/2001 | EP1091726A2 Analogs of 2-phthalimidinoglutaric acid and their use as inhibitors of angiogenesis |
| 04/18/2001 | EP0915823B1 Bi-aromatic compounds, pharmaceutical and cosmetic compositions containing same and uses |
| 04/18/2001 | EP0731697B1 Ssi tyrphostins and pharmaceutical compositions |
| 04/18/2001 | EP0579827B1 Method of preparing 2-arylbenzimidazole 5-sulphonic acids |
| 04/18/2001 | CN1292032A Self-regulated apoptosis of inflammatory cells by gene therapy |
| 04/18/2001 | CN1291993A Thiadiazole compounds useful as inhibitors of cysteine activity dependent enzymes |
| 04/18/2001 | CN1291974A Cyclohexanediole derivatives |
| 04/18/2001 | CN1291897A Inorganic nitrite and organic acid in combination as topical antiviral composition |
| 04/18/2001 | CN1291895A Polymeric compounds and methods of formulating same |
| 04/18/2001 | CN1291509A Medicinal composition for treating psoriasis |
| 04/18/2001 | CN1291494A Aloe-eelgrass capsule 'Pifukang' and its preparing process |
| 04/18/2001 | CN1291492A Hair-growing lotion |
| 04/18/2001 | CN1291485A Medicine for quickly treating acne abscess and its preparing process |
| 04/18/2001 | CN1291477A Medicinal composition for treating optical atrophy |
| 04/18/2001 | CN1064710C Therapeutic uses of keratinocyte growth factor |
| 04/18/2001 | CN1064540C Medicine for burn and scald and preparing process |
| 04/17/2001 | US6218537 Process for making pyridyl and pyrimidine substituted imidazole compounds |
| 04/17/2001 | US6218435 Reduction of hair growth |
| 04/17/2001 | US6218430 Vitamin D3 mimics |
| 04/17/2001 | US6218423 Administering pyrrolidine derivative for therapy of nerve-related vision disorder, improving vision, treating memory impairment, or enhancing memory performance in animal |
| 04/17/2001 | US6218418 Therapy of cell proliferative disorders associated with an altered cell dependent kinase activity by administering amino pyrazole derivative to mammal |
| 04/17/2001 | US6218389 For therapy and prophylaxis of arthritis, cancer, cardiovascular disorders; skin disorders; ocular disorders; inflammation and gum diseases, multiple sclerosis, cachexia, preventing loosening of prosthetic devices |
| 04/17/2001 | US6218159 Amino acid sequence; bacteriostats; bactericides; antibiotics; diagnosis of infections; drug screening |
| 04/17/2001 | US6217914 Ascorbic acid composition and method for treatment of aging or damaged skin |
| 04/17/2001 | US6217889 Personal care articles |
| 04/17/2001 | US6217880 Medicament for treating recurrent ulcer of mouth and behcet's syndrome |
| 04/17/2001 | US6216707 Use of at least an Irvingia gabonensis extract in a cosmetic and/or pharmaceutical product |
| 04/17/2001 | CA2196054C Dihydrobenzofuran and related compounds useful as anti-inflammatory agents |
| 04/17/2001 | CA2163107C Improved detection and therapy of lesions with biotin/avidin-metal chelating protein conjugates |
| 04/17/2001 | CA2103044C Novel bi-aromatic compounds derived from a salicylic pattern, method of preparation and use in human and veterinary medicine and in cosmetics |
| 04/12/2001 | WO2001025486A1 Methods for identifying rna binding compounds |
| 04/12/2001 | WO2001025442A1 Dna polymerase lambda and uses thereof |
| 04/12/2001 | WO2001025438A2 Ifn-alpha homologues |
| 04/12/2001 | WO2001025433A2 Novel polypeptides, their nucleic acids, and methods for their use in angiogenesis and vascularization |